The Anti-Senescence Therapeutics Market is entering a new phase of Molecular Biosensors Market Accelerates as Point-of-Care Testing Moves Toward Fa The global Molecular Biosensors Market was valued at USD 30.80 billion in 2024, increased to USD 33.55 billion in 2025, and is estimated to reach USD 36.55 billion in 2026
ME/CFS is characterized more by overwhelming fatigue after minimal physical or mental exertion (post-exertional malaise), while fibromyalgia is known more for widespread pain and tender points
While the opportunity for oral GLP-1s is substantial, realising its full potential will depend on how effectively pharmaceutical companies and CDMOs navigate the associated challenges
These drugs can improve metabolic health, reducing inflammation and insulin resistance, which are risk factors for CRC
Zhou H, Mak PY, Mu H, Mak DH, Zeng Z, Cortes J, Amdreeff M, Carter BZ
doi: 10.3322/caac.21388